Read + Share
Amedeo Smart
Independent Medical Education
Afzal A, Tarbunova M, Despotis G, Grossman BJ, et al. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD). Transfusion 2020 Jan 9. doi: 10.1111/trf.15653.PMID: 31919871
Email
LinkedIn
Facebook
Twitter
Privacy Policy